Skip to main content

Retatrutide

Retatrutide is like the ultimate metabolic multitasker—a next-gen peptide that fires up multiple hormone pathways to support weight loss, appetite control, and overall metabolic balance.

Retatrutide is an advanced medication being studied for major weight loss and metabolic improvements in people with obesity or type 2 diabetes. It works by activating three different hormone pathways that help control appetite, energy use, and blood sugar.


How It Works

Retatrutide is a “triple agonist,” meaning it activates three metabolic hormone receptors at the same time:

  • GLP-1: Helps lower appetite and slows how fast your stomach empties

  • GIP: Supports insulin release and may help with fat metabolism

  • Glucagon: Increases how many calories your body burns and encourages the body to use fat for energy

Because it hits all three pathways at once, the effect is stronger than medications that target only one or two.

Retatrutide stays active in the body for about 6 days, so it’s designed for once-weekly injections.

In clinical trials:

  • People taking 12 mg weekly lost about 24% of their body weight over 48 weeks.

  • In people with type 2 diabetes, it led to about 17% weight loss at 36 weeks and lowered A1C by roughly 2.0%.

  • A 2025 analysis of three studies showed significantly greater weight loss than placebo, without more overall side effects.

Compare to traditional GLP-1(Ozempic)

Ozempic (semaglutide)

  • Activates only one pathway: GLP-1

  • GLP-1 reduces appetite, slows stomach emptying, and helps control blood sugar.

Retatrutide

  • Activates three pathways at the same time:

    • GLP-1 (same as Ozempic)

    • GIP (boosts insulin + may help with fat metabolism)

    • Glucagon (increases energy burning + fat use)

This triple action makes Retatrutide stronger overall. Retatrutide causes more weight loss.

Clinical trial averages:

  • Ozempic: ~10–15% body weight loss

  • Retatrutide: ~20–24% body weight loss (in higher doses)

Retatrutide produced some of the largest weight-loss results ever seen in a medication trial.

Retatrutide burns more calories

Because it activates the glucagon receptor, Retatrutide:

  • Increases energy expenditure

  • Helps the body burn more fat

  • Has more metabolic activity than Ozempic

Ozempic doesn’t do this. Since it hits multiple pathways, it may help when GLP-1 alone (like Ozempic) isn’t enough.


Potential Benefits & Side Effects

Potential Benefits

  • Significant weight loss: Up to 24% body weight reduction in studies

  • Better blood sugar control: Around a 2% drop in A1C in type 2 diabetes

  • Metabolic improvements: Better cholesterol, blood pressure, and heart-health markers

  • Easy to use: Once-weekly injections help with consistency


Common Side Effects

  • Digestive issues: Nausea, diarrhea, vomiting, or constipation—usually mild and improve with time

  • Starting at a lower dose (2 mg weekly) helps reduce early stomach side effects

  • Injection site reactions: Mild redness or swelling may occur

  • Overall, studies found no significant increase in total side effects compared to placebo


Dosage Guide


Disclaimer:

All peptide products sold on this website are for research, laboratory, and educational purposes only. They are not approved by the FDA or Health Canada, are not intended for human consumption, and should not be used for medical, cosmetic, or therapeutic purposes unless specifically prescribed by a licensed healthcare professional.

The information provided on this site is for informational and educational purposes only and does not constitute medical advice. Product descriptions, protocols, or references are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before beginning any new protocol, supplement, or treatment.

By purchasing from this website, you acknowledge and agree to use these products responsibly and in accordance with all applicable laws and guidelines.

Did this answer your question?